Idiopathic Pulmonary Fibrosis Algorithm Performs Poorly

This article originally appeared here.
Share this content:
Idiopathic Pulmonary Fibrosis Algorithm Performs Poorly
Idiopathic Pulmonary Fibrosis Algorithm Performs Poorly

TUESDAY, June 13, 2017 (HealthDay News) -- The traditional idiopathic pulmonary fibrosis (IPF) algorithm performs poorly, with positive predictive value of 42.2 percent and sensitivity of 55.6 percent, according to a study published in the June 1 issue of the Annals of the American Thoracic Society.

Brett Ley, M.D., from the University of California in San Francisco, and colleagues identified potential cases of IPF in the Kaiser Permanente Northern California adult population from 2000 to 2014 using the traditional IPF algorithm. A subset of 150 cases were validated by expert medical record and chest computed tomography review. To optimize positive predictive value, a modified IPF algorithm was derived and validated.

The researchers identified 2,608 cases among 5,389,627 at-risk adults using the traditional IPF algorithm. The annual incidence was 6.8/100,000 person-years, and was elevated for patients who were older, male, and white. For the IPF algorithm the positive predictive value was 42.2 percent, and the sensitivity was 55.6 percent. The estimated corrected incidence was 5.6/100,000 person-years. Compared with the traditional algorithm, the modified IPF algorithm improved positive predictive value but reduced sensitivity.

"A modification of the IPF algorithm may be useful for future population-based studies of IPF," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: More Than 400 Sickened by McDonald's Salads

CDC: More Than 400 Sickened by McDonald's Salads

Multistate outbreak of Cyclosporiasis linked to McDonald's Fresh Express Salad Mix

Jury Awards 289 Million in Case Linking Roundup to Man's Cancer

Jury Awards $289 Million in Case Linking Roundup ...

Case could set a precedent for other lawsuits against Monsanto, the manufacturer of Roundup

Prenatal Tdap Vaccination Not Linked to Autism Risk

Prenatal Tdap Vaccination Not Linked to Autism Risk

No increased risk of autism spectrum disorder in association with prenatal Tdap vaccination

is free, fast, and customized just for you!




Already a member?

Sign In Now »